Sanoptis – Startup Investor Profile

Sanoptis is an innovative European ophthalmology services group, covering the full spectrum of diagnostic and surgical ophthalmic treatments

Location: Pfaffikon

Country:

Investment Regions: EU

Investment Stages: pre-seed, seed

Website: https://www.sanoptis.com/

AI Reasoning: I found a disclosed investment by Sanoptis: it led the first close of an $8M Series B in Ikerian (RetinAI/ Ikerian) on Oct 16, 2024. Calculating from that date to today gives a gap of about 12 months and 16 days, which falls within the 12-to-6-month window boundary; therefore classification corresponds to ‘low-active’ by definitions. However, there is also a major growth capital transaction where Carlyle provided €250M to Sanoptis on Mar 17, 2025 (Sanoptis secured €250M growth capital), which is within 3 months prior to today, indicating very recent activity. The most recent known investment-related activity is Mar 17, 2025 (investment/ financing related), which is less than 8 months before today – under 3 months? Wait recalculating: Mar 17 to Nov 1 is 7 months and 15 days, which places it between 12 and 6 months? Correction: Mar 17 to Nov 1 is 7.5 months, so between 12 and 6 months inclusive -> ‘low-active’. But the Ikerian date Oct 16, 2024 is older. The most recent is Mar 17, 2025; therefore the correct tag is ‘low-active’.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.